Global Infectious Disease Treatment Market Overview:
Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Many organisms live in bodies. They are normally harmless or even helpful. However, under certain conditions, some organisms may cause disease. Some infectious diseases can be passed from person to person. Insects or other animals transmit some. In addition, may get others by consuming contaminated food or water or being exposed to organisms in the environment. Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild infections may respond to rest and home remedies, while some life-threatening infections may need hospitalization. Treatment depends on which microorganism causes the infection. If bacteria cause disease, treatment with antibiotics usually kills the bacteria and ends the infection. Viral infections are usually treated with supportive therapies, like rest and increased fluid intake
- Rising prevalence of Infectious Disease
- Rising geriatric population
- Lack of awareness about the disease
- Technical complexities related to diagnostic test
- High governmental healthcare expenditure
- Surging insurance penetration
- Limited expertise and high cost of treatment
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Pfizer, Inc. (United States), ABBVIE (United States), Amgen (United States), Roche (Switzerland), Merck & Co., Inc. (aka MSD) (United States), Genentech (United States), emocha Mobile Health (United States), Inovio Pharmaceuticals (United States), Sanofi (France) and GlaxoSmithKline (GSK) (United Kingdom). Additionally, following companies can also be profiled that are part of our coverage like Soligenix (United States), Heat Biologics (United States) and Regeneron (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Infectious Disease Treatment market by 2026. Considering Market by Treatment, the sub-segment i.e. Antibiotics will boost the Infectious Disease Treatment market. Considering Market by Cause, the sub-segment i.e. Viruses will boost the Infectious Disease Treatment market. Considering Market by Diagnosis, the sub-segment i.e. Laboratory tests will boost the Infectious Disease Treatment market. Considering Market by Symptoms, the sub-segment i.e. Fever will boost the Infectious Disease Treatment market.
Latest Market Insights:
On 9 September 2021, Roche announced that it has entered a share purchase agreement to acquire 100 percent of the outstanding shares of the TIB Molbiol Group. The deal is expected to close in the fourth quarter of 2021. Financial and other terms were not disclosed., Roche statement that the acquisition will enhance its portfolio of molecular diagnostic solutions for infectious diseases., and On 28 April 2021, Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx’s lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections.
On 5 December 2019 The U.S. Food and Drug Administration today announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new drugs for neglected diseases. The repository is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH).
What Can be Explored with the Infectious Disease Treatment Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Infectious Disease Treatment Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Infectious Disease Treatment
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Infectious Disease Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Infectious Disease Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Infectious Disease Treatment Provider, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Infectious Disease Treatment Market?
The Infectious Disease Treatment market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Infectious Disease Treatment Market?
Top performing companies in the Global Infectious Disease Treatment market are Pfizer, Inc. (United States), ABBVIE (United States), Amgen (United States), Roche (Switzerland), Merck & Co., Inc. (aka MSD) (United States), Genentech (United States), emocha Mobile Health (United States), Inovio Pharmaceuticals (United States), Sanofi (France) and GlaxoSmithKline (GSK) (United Kingdom), to name a few.
3. What trending factors would impact Infectious Disease Treatment Market growth most?
"High Investments in Healthcare R&D" is seen as one of major influencing trends for Infectious Disease Treatment Market during projected period 2020-2026.